The Bloomington-based maker of medical devices said Wednesday it would appeal the verdict of a federal jury in Indianapolis, which found the device was defectively designed. More than 4,000 patients have filed lawsuits.
The Indianapolis-based pharmaceutical giant on Wednesday tempered expectations for its earnings in 2019 after a promising cancer drug failed to pan out and the firm prepared for big acquisition.
When the $175 million hospital opens in stages over the next two weeks, patients and visitors will see a major upgrade in facilities.
For hospitals, maternity care builds relationships with young families that often last for decades. About 40 percent of women experience their first encounter with hospitals for reproductive services.
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Indiana University Health and Community Health Network have joined the national trend of posting online reviews, in a quest to win prospective patients and boost transparency.
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
The Indianapolis-based provider of health clinics for businesses has grown to 250 employees in 10 years. But it recently started looking for another owner.
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
The dispute between the world’s largest retail chain and the prominent pharmacy-benefits manager could roil the business of filling prescriptions.
The ringleader in one of the largest corporate-fraud cases in Indiana in recent years says his legal team at Barnes & Thornburg failed to disclose a “profound conflict of interest.
Indianapolis hospitals are among those in the state imposing restrictions on visitors to try to curb the spread of flu.
A prolonged shutdown could muddle Eli Lilly and Co.’s plan to unload its stake in Elanco Animal Health Inc., the unit it spun off last year, Lilly CEO Dave Ricks said.
Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say.
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Bristol-Myers and Celgene combined will have nine products with more than $1 billion in annual sales and significant potential for growth in the core disease areas of oncology, immunology and cardiovascular disease.
While many analysts expect the ruling to be reversed by higher courts, the news adds to volatility in a sector that had barely recovered from political static this year.
The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
